| abstract |
Prodrugs of proton pump inhibitors of Formulas 1 through 4, n nwhere the symbols are as defined in the specification, and the R group includes at least one acidic group or its pharmaceutically acceptable salt, have improved aqueous solubility and bioavailability. |